Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 192.00K | 0.00 | 0.00 | 0.00 | 0.00 | 120.00K |
Gross Profit | 95.00K | -359.00K | -374.00K | -373.00K | -195.00K | -63.00K |
EBITDA | -77.41M | -35.39M | -116.16M | -87.59M | -36.66M | -23.03M |
Net Income | -19.05M | -35.32M | -40.33M | -87.50M | -34.51M | -22.81M |
Balance Sheet | ||||||
Total Assets | 161.31M | 177.41M | 89.07M | 92.79M | 170.55M | 197.19M |
Cash, Cash Equivalents and Short-Term Investments | 124.88M | 140.18M | 51.10M | 56.41M | 84.83M | 114.19M |
Total Debt | 880.00K | 954.00K | 383.00K | 746.00K | 769.00K | 144.00K |
Total Liabilities | 46.73M | 59.27M | 81.86M | 8.61M | 6.55M | 6.59M |
Stockholders Equity | 114.58M | 118.14M | 7.21M | 84.18M | 164.00M | 190.60M |
Cash Flow | ||||||
Free Cash Flow | -54.59M | -47.27M | -39.53M | -28.42M | -28.91M | -15.21M |
Operating Cash Flow | -54.59M | -47.27M | -39.53M | -28.42M | -28.91M | -15.21M |
Investing Cash Flow | -76.20M | -70.31M | -45.29M | 0.00 | 0.00 | 11.04M |
Financing Cash Flow | 133.64M | 133.52M | 33.02M | 0.00 | -449.00K | 109.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | 164.25M | 27.84 | 6.79% | ― | 62.79% | ― | |
52 Neutral | 53.44M | -0.81 | ― | ― | -41.18% | -21.12% | |
51 Neutral | 281.00M | -4.88 | -45.35% | ― | 91.44% | 18.94% | |
47 Neutral | 542.80M | -3.20 | ― | ― | ― | 21.30% | |
40 Neutral | 274.74M | -3.92 | 98.35% | ― | -31.30% | 36.26% | |
35 Underperform | $161.08M | ― | -16.20% | ― | ― | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Eledon Pharmaceuticals announced an amendment to the employment agreement of its CEO, David-Alexandre Gros, adjusting the market value cap for his performance bonus. The CEO’s bonus structure has been altered, allowing for a maximum bonus of $15 million if the company’s market value reaches $1.5 billion, with linear interpolation determining payouts between set thresholds.